Hospitalized poisonings after renal transplantation in the United States

BMC Nephrology

Volumn 3, Issue , 2002, Pages 1-8

  Abbott, Kevin C ^a,b   Viola, Rebecca A ^a   Agodoa, Lawrence Y ^c  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Body mass index; Complications; Diabetes; Drug overdose; Medication error; Pharmacist; Poisonings; Rejection; USRDS

Indexed keywords

ANALGESIC AGENT; ANTIALLERGIC AGENT; ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; ANTIEMETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTINEOPLASTIC AGENT; ANTIPYRETIC AGENT; BENZODIAZEPINE; CORTICOSTEROID; HYDANTOIN; IMMUNOSUPPRESSIVE AGENT; INSULIN; OPIATE; PSYCHOSTIMULANT AGENT; PSYCHOTROPIC AGENT; SALICYLIC ACID DERIVATIVE; TRANQUILIZER;

ARTICLE; BODY MASS; CONTROLLED STUDY; DRUG FATALITY; DRUG INTOXICATION; FEMALE; GRAFT REJECTION; HAZARD ASSESSMENT; HOSPITALIZATION; HUMAN; INCIDENCE; INFORMATION PROCESSING; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; POSTOPERATIVE CARE; REGRESSION ANALYSIS; RISK FACTOR; SURVIVAL TIME; UNITED STATES; ADULT; COHORT ANALYSIS; COMORBIDITY; DIABETES MELLITUS; DRUG OVERDOSE; EPIDEMIOLOGY; INTOXICATION; MEDICATION ERROR; MULTIVARIATE ANALYSIS; SEX DIFFERENCE; STATISTICS; SURVIVAL RATE;

ADULT; ANALGESICS; BODY MASS INDEX; CAUSALITY; COHORT STUDIES; COMORBIDITY; DIABETES MELLITUS; DRUG OVERDOSE; FEMALE; HOSPITALIZATION; HUMANS; HYPOGLYCEMIC AGENTS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; KIDNEY TRANSPLANTATION; MALE; MEDICATION ERRORS; MULTIVARIATE ANALYSIS; POISONING; PSYCHOTROPIC DRUGS; RISK FACTORS; SEX FACTORS; SURVIVAL RATE; UNITED STATES;

EID: 3343017231     PISSN: 14712369     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-3-10     Document Type: Article

References (24)

1. [http://www.cdc.gov/nchs]
2. Chang SH, Lim CS, Low TS, Chong HT, Tan SY: Cyclosporine-associated encephalopathy: a case report and literature review. Transplant Proc 2001, 33:3700-1
3. Wong EH, Chan NN, Sze KH, Or KH: Serotonin syndrome in a renal transplant patient. J R Soc Med 2002, 95:304-5
4. Chari RS, Hemming AW, Cattral M: Successful kidney pancreas transplantation from donor with methanol intoxication. Transplantation 1998, 66:674-5
5. Ravishankar DK, Kashi SH, Lam FT: Organ transplantation from donor who died of cyanide poisoning: a case report. Clin Transplant 1998, 12:142-3
6. Abbott KC, Duran M, Hypolite I, et al: Hospitalizations for bacterial endocarditis after renal transplantation in the United States. J Nephrol 2001, 14:353-60
7. Tveit DP, Hypolite I, Bucci J, et al: Risk factors for hospitalizations resulting from pulmonary embolism after renal transplantation in the United States. J Nephrol 2001, 14:361-8
8. Abbott KC, Hypolite IO, Hshieh P, et al: Hospitalized congestive heart failure after renal transplantation in the United States. Ann Epidemiol 2002, 12:115-22
9. Abbott KC, Bucci JR, Cruess D, Taylor AJ, Agodoa LY: Graft loss and acute coronary syndromes after renal transplantation in the United States. J Am Soc Nephrol 2002, 13:2560-9
10. Hypolite IO, Bucci J, Hshieh P, Cruess D, Agodoa LY, Yuan CM, Taylor AJ, Abbott KC: Acute coronary syndromes after renal transplantation in patients with end-stage renal disease resulting from diabetes. Am J Transplant 2002, 2:274-81
11. David Kleinbaum G: Survival Analysis: A Self-Learning Text (Statistics in the Health Sciences) Springer Verlag; New York, New York May 1996
12. Kruger HU, Bross-Bach U, Proksch B, Schmidt H, Dopfer R, Ehninger G: A case of accidental cyclosporin overdose with pharmacokinetic analysis. Bone Marrow Transplant 1988, 3:167-9
13. Yeh CN, Hsieh CH, Hung CM, Jeng LB, Chao TC, Chen MF: Acute overdoses of tacrolimus (FK 506). Dig Dis Sci 1999, 44:1650-2
14. Dines CM: Improving renal transplant pain management. Hosp Case Manag 1999, 7:105-7
15. Abbott K, Hypolite I, Viola R, Poropatich R, Hshieh P, Cruess D, Hawkes C, Agodoa L: Hospitalizations for cytomegalovirus disease after renal transplantation in the United States. Ann Epidemiol 2002, 12:402
16. Bechstein WO: Neurotoxicity of calcineurin inhibitors: impact and clinical management. Transpl Int 2000, 13:313-26
17. Vella JP, Sayegh MH: Interactions between cyclosporine and newer antidepressant medications. Am J Kidney Dis 1998, 31:320-3
18. Matzke GR, St Peter WL, Comstock TJ, Foote EF: Nephrology pharmaceutical care preceptorship: a programmatic and clinical outcomes assessment. Ann Pharmacother 2000, 34:593-9
19. Kliger AS, Diamond LH: Patient safety in end-stage renal disease: How do we create a safe environment? Adv Ren Replace Ther 2001, 8:131-7
20. Wong KM, Shek CC, Chau KF, Li CS: Abbreviated Tacrolimus Area-Under-the-Curve Monitoring for Renal Transplant Recipients. Am J Kidney Dis 2000, 35(4):660-666
21. [http://www.wramc.amedd.army.mil/departments/Medicine/Nephrology/sop/txp/ txpmedprotocol.cfm]8/27/2002
22. Chisholm MA, Mulloy LL, Jagadeesan M, DiPiro JT: Impact of clinical pharmacy services on renal transplant patients' compliance with immunosuppressive medications. Clin Transplant 2001, 15:330-6
23. Estimating workforce and training requirements for nephrologists through the year 2010. Ad Hoc Committee on Nephrology Manpower Needs. J Am Soc Nephrol 1997, 8:S9-13i-xxii, 1-32 passim
24. Bond MA: Health promotion and disease prevention in kidney transplant recipients. J Transpl Coord 1998, 8:221-4